Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy

被引:101
作者
Arkblad, Eva L. [1 ]
Darin, Niklas
Berg, Kerstin
Kimber, Eva
Brandberg, Goeran
Lindberg, Christopher
Holmberg, Eva
Tulinius, Mar
Nordling, Margareta
机构
[1] Sahlgrens Univ Hosp E, Dept Clin Genet, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, S-41345 Gothenburg, Sweden
[3] Uppsala Univ, Childrens Hosp, Dept Neuropaediat, Uppsala, Sweden
[4] Falun Cent Hosp, Dept Paediat, Falun, Sweden
[5] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Clin Neurosci, S-41345 Gothenburg, Sweden
关键词
MLPA; SMA; diagnostics; gene dosage;
D O I
10.1016/j.nmd.2006.08.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal muscular strophy (SMA) is an autosomal recessive disease caused by decreased levels of survival motor neuron protein (SMN). In the majority of cases, this decrease is due to absence of the SMN1 gene. Multiplex ligation-dependent probe amplification (MLPA) is a modern quantitative molecular method. Applied in SMA cases. it improves diagnostics by simultaneously identifying the number of copies of several target sequences in the SMN1 gene and in neary genes. Using MLPA in clinical diagnostics, we have identified a previously unreported, partial deletion of SMN1 (exons 1-6) in two apparently unrelated Swedish families. this mutation would not have been detected by conventional diagnostic methods. This paper illustrates the broad clinical and genetic spectrum of SMA and includes reports of MLPA results and clinical dexcriptions of a patient with homozygous absence of SMN1 and only one SMN2 (prenatal onset SMA type 1), an asymptomatic woman with five SMN2 (lacking SMN1) and representative patients with SMA types 1,2 and 3. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:830 / 838
页数:9
相关论文
共 19 条
[1]   Determination of SMN1 and SMN2 copy number using TaqMan™ technology [J].
Anhuf, D ;
Eggermann, T ;
Rudnik-Schöneborn, S ;
Zerres, K .
HUMAN MUTATION, 2003, 22 (01) :74-78
[2]   Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations [J].
Clermont, O ;
Burlet, P ;
Benit, P ;
Chanterau, D ;
Saugier-Veber, P ;
Munnich, A ;
Cusin, V .
HUMAN MUTATION, 2004, 24 (05) :417-427
[3]   Prevalence of SMN1 deletion and duplication in carrier and normal populations:: implication for genetic counselling -: art. no. e39 [J].
Cusin, V ;
Clermont, O ;
Gérard, B ;
Chantereau, D ;
Elion, J .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (04)
[4]  
DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218
[5]   The SMN complex [J].
Gubitz, AK ;
Feng, WQ ;
Dreyfuss, G .
EXPERIMENTAL CELL RESEARCH, 2004, 296 (01) :51-56
[6]   DE-NOVO AND INHERITED DELETIONS OF THE 5Q13 REGION IN SPINAL MUSCULAR ATROPHIES [J].
MELKI, J ;
LEFEBVRE, S ;
BURGLEN, L ;
BURLET, P ;
CLERMONT, O ;
MILLASSEAU, P ;
REBOULLET, S ;
BENICHOU, B ;
ZEVIANI, M ;
LEPASLIER, D ;
COHEN, D ;
WEISSENBACH, J ;
MUNNICH, A .
SCIENCE, 1994, 264 (5164) :1474-1477
[7]   The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy [J].
Monani, UR ;
Sendtner, M ;
Coovert, DD ;
Parsons, DW ;
Andreassi, C ;
Le, TT ;
Jablonka, S ;
Schrank, B ;
Rossol, W ;
Prior, TW ;
Morris, GE ;
Burghes, AHM .
HUMAN MOLECULAR GENETICS, 2000, 9 (03) :333-339
[8]   New insights on the evolution of the SMN1 and SMN2 region:: simulation and meta-analysis for allele and haplotype frequency calculations [J].
Ogino, S ;
Wilson, RB ;
Gold, B .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (12) :1015-1023
[9]   Spinal muscular atrophy: molecular genetics and diagnostics [J].
Ogino, S ;
Wilson, RB .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (01) :15-29
[10]   Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2 [J].
Prior, TW ;
Swoboda, KJ ;
Scott, HD ;
Hejmanowski, AQ .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 130A (03) :307-310